Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Horak

Showing results (121-130 of 136) with videos related to

Pageof 14
Sort By:
Nature Communications|April 11, 2019
Defective homologous recombination DNA repair as therapeutic target in advanced chordomaStefan Gröschel, Daniel Hübschmann, Francesco Raimondi, et al.
Cancer Discovery|May 27, 2018
<i>NRG1</i> Fusions in <i>KRAS</i> Wild-Type Pancreatic CancerChristoph Heining, Peter Horak, Sebastian Uhrig, et al.
International Journal of Cancer|April 23, 2019
Variant classification in precision oncologyJonas Leichsenring, Peter Horak, Simon Kreutzfeldt, et al.
Nature Communications|August 2, 2022
Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneityLino Möhrmann, Maximilian Werner, Małgorzata Oleś, et al.
NPJ Precision Oncology|October 20, 2023
Multicentric pilot study to standardize clinical whole exome sequencing (WES) for cancer patientsMichael Menzel, Stephan Ossowski, Sebastian Kral, et al.
JCO Precision Oncology|February 9, 2022
Validating Comprehensive Next-Generation Sequencing Results for Precision Oncology: The NCT/DKTK Molecularly Aided Stratification for Tumor Eradication Research ExperienceAmelie Lier, Roland Penzel, Christoph Heining, et al.
Nature Communications|April 9, 2026
Multi-layered molecular profiling informs the diagnosis and targeted therapy of desmoplastic small round cell tumorMarcus Renner, Małgorzata Oleś, Nagarajan Paramasivam, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 5, 2022
Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)Peter Horak, Malachi Griffith, Arpad M Danos, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 19, 2022
Bcl-x<sub>L</sub> as prognostic marker and potential therapeutic target in cholangiocarcinomaPaula Hoffmeister-Wittmann, Andreas Mock, Federico Nichetti, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 1, 2022
Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)Peter Horak, Malachi Griffith, Arpad M Danos, et al.
Pageof 14

Showing results (121-130 of 136) with videos related to

Sort By:
Pageof 14
Nature Communications|April 11, 2019
Defective homologous recombination DNA repair as therapeutic target in advanced chordomaStefan Gröschel, Daniel Hübschmann, Francesco Raimondi, et al.
Cancer Discovery|May 27, 2018
<i>NRG1</i> Fusions in <i>KRAS</i> Wild-Type Pancreatic CancerChristoph Heining, Peter Horak, Sebastian Uhrig, et al.
International Journal of Cancer|April 23, 2019
Variant classification in precision oncologyJonas Leichsenring, Peter Horak, Simon Kreutzfeldt, et al.
Nature Communications|August 2, 2022
Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneityLino Möhrmann, Maximilian Werner, Małgorzata Oleś, et al.
NPJ Precision Oncology|October 20, 2023
Multicentric pilot study to standardize clinical whole exome sequencing (WES) for cancer patientsMichael Menzel, Stephan Ossowski, Sebastian Kral, et al.
JCO Precision Oncology|February 9, 2022
Validating Comprehensive Next-Generation Sequencing Results for Precision Oncology: The NCT/DKTK Molecularly Aided Stratification for Tumor Eradication Research ExperienceAmelie Lier, Roland Penzel, Christoph Heining, et al.
Nature Communications|April 9, 2026
Multi-layered molecular profiling informs the diagnosis and targeted therapy of desmoplastic small round cell tumorMarcus Renner, Małgorzata Oleś, Nagarajan Paramasivam, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 5, 2022
Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)Peter Horak, Malachi Griffith, Arpad M Danos, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 19, 2022
Bcl-x<sub>L</sub> as prognostic marker and potential therapeutic target in cholangiocarcinomaPaula Hoffmeister-Wittmann, Andreas Mock, Federico Nichetti, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 1, 2022
Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)Peter Horak, Malachi Griffith, Arpad M Danos, et al.
Pageof 14